More Galleries
7 lifehacks to eliminate your holiday hassle Whether curating the perfect gift or finding a pet-sitter, these startups offer time-saving services that might just seem like holiday magic. More
San Francisco: The best city to make things From electric motorcycles to death shrouds, San Francisco's manufacturing sector is booming. More
6 designers shaking up fashion These designers are changing the way we dress, accessorize and shop, from custom made-to-fit dresses to smart jewelry that's actually stylish. More

Special Offer
3 of 36
3rd place: How to live forever
3rd place: How to live forever
Raymond Sekula and Sasha Bakhru
Team name: NeuroBank

School: Carnegie Mellon University, Tepper School of Business

Team members: Raymond Sekula, Sasha Bakhru

Concept: NeuroBank plans to use proprietary technology to isolate, purify, expand and store adult neural stem cells. The company, through its product NeuroBank, will tap into the market of neurologic disease sufferers who wish to harvest and store their neural stem cells before they deteriorate in quantity or quality due to age or disease.

Therapies that could use such cells to treat diseases such as strokes, epilepsy, multiple sclerosis and more are still many years away. But NeuroBank believes that 13.6 million people currently suffer from illnesses that could be cured using neural stem cells, creating a $4-billion market opportunity for cell storage.

In exchange for each customer's initiation fee, NeuroBank will provide a kit that will allow partner physicians to isolate the neural stem cells. The cells will then be shipped to NeuroBank's processing laboratories. Customers will also pay an annual storage fee. NeuroBank will provide customers with flexible monthly payment options.

The Carnegie-Mellon team is led by Raymond Sekula, a trained neurosurgeon, who is currently pursuing his MBA at Tepper. Dr. Sekula is the company's chief scientist and will also serve as initial CEO.

The company's business plan hinges on its proprietary technology. It is currently awaiting the results of patent applications filed in the U.S. and internationally.

Timeline: At the seed stage, NeuroBank plans to continue with research and expand its intellectual property portfolio. It will develop a commercial laboratory, and build a marketing network through insurance companies. - Candice Zachariahs

NEXT: 4th place: Wirelessly zapping pain

Last updated May 02 2008: 11:51 AM ET

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.